The largest database of trusted experimental protocols

12 protocols using otx015

1

Comparing Cytostatic Compound Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Actinomycin D, BTYNB, DZNep and OTX015 were purchased from Cayman Chemical. The compounds were dissolved in DMSO.
+ Open protocol
+ Expand
2

Combinatorial Inhibitor Treatment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HDI romidepsin (Cat #S3020) and the ERK inhibitor ulixertinib (Cat #S7854) were purchased from Selleck Chemicals (Houston, TX, USA). The PI3K inhibitor GDC-0941 (Cat #CT-G0941) and mTOR inhibitors AZD-8055 (Cat #CT-A8055) and NVP-BEZ235 (Cat #CT-BEZ) were from ChemieTek (Indianapolis, IN, USA). The mTOR inhibitor rapamycin (Cat #1292) was obtained from Tocris/R&D Systems (Minneapolis, MN, USA). The BRD inhibitor OTX-015 (Cat #15947) was purchased from Cayman Chemicals (Ann Arbor, MI, USA). The pan-caspase inhibitor Q-VD-OPh (Cat #A1901) was obtained from ApexBio Technology (Houston, TX, USA).
+ Open protocol
+ Expand
3

Cultivation and Proliferation of ATL Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
DMEM (Invitrogen) with 10% FBS (Atlanta Biologicals) was used for 293 T cell culture and maintained in 5% CO2 at 37 °C. The ATL patient-derived cell lines MT1, ATL25, ED-40515(−), Tl-Om1, and ATLT, along with the HTLV-I cell line, MT4, were cultured in RPMI-1640 (Invitrogen) with 10% FBS in 5% CO2 at 37 °C. The ATL patient-derived cell lines, KOB, KK1, ATL55T, and ATL43T, were cultured in RPMI-1640 with 20% FBS and 50 U/ml IL-2. Cell proliferation was analyzed by XTT assays (Trevigen) or by microscopic cell counts at different times after drug treatment as indicated in the figure legends. JQ1, OTX015, and AG490 were purchased from Cayman Chemical. Dinaciclib (SCH727965), PLX8394, Sorafenib, and Ulixertinib (BVD-523) selective inhibitors were purchased from Selleckchem.
+ Open protocol
+ Expand
4

Small Molecule Inhibitor Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chloroquine (Cat#: C6628), Doxycycline (Cat#: D9891), Antimycin A (Cat#: A8674), Oligomycin (Cat#: O4876), D-(+)-Trehalose dihydrate (Cat#: T0167), and 4-Hydroxytamoxifen (Cat#: H7904) were from Sigma-Aldrich. (+)-JQ1 (Cat#: 4499) and I-BET151 (Cat#: 4650) were from TOCRIS. OTX015 (Cat#: 15947) was from Cayman. Compound C (Cat#: 171264) was from EMD Millipore. Rapamycin (Cat#: R-5000) was from LC Laboratories. ARV-825 was from Chemietek (Cat#: CT-ARV825).
+ Open protocol
+ Expand
5

Detailed Reagents and Antibodies Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
(+)-JQ1 was purchased from ApexBio (Houston, TX). OTX015 and MS436 were purchased from Cayman Chemical (Ann Arbor, MI). Soluble recombinant human TRAIL was purchased from PeproTech, Inc. (Rocky Hill, NJ). MG132, cycloheximide (CHX) and PFI-1 were purchased from Sigma Chemical Co. (St. Louis, MO). Monoclonal anti-FLIP antibody (NF6) was obtained from Alexis Biochemicals (San Diego, CA). Mouse monoclonal caspase-8, PARP, survivin and c-Myc antibodies were purchased from Cell Signaling Technology, Inc. (Danvers, MA). Mouse monoclonal caspase-3 antibody was purchased from Imgenex (San Diego, CA). Rabbit polyclonal DR5 antibody was obtained from ProSci Inc. (Poway, CA). Mouse monoclonal DR4 antibody (B-N28) was purchased from Diaclone (Stamford, CT). Rabbit polyclonal Mcl-1 and Bcl-XL/S and mouse monoclonal Bcl-2 antibody were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Tubulin and GAPDH antibodies were purchased from Sigma Chemical Co. and Trevigen Inc. (Gaithersburg, MD), respectively.
+ Open protocol
+ Expand
6

Diverse Small Molecule Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
ARV-825, dBET1, (+)-JQ1, OTX015 and pomalidomide were purchased from Cayman. MZ1, THAL SNS 032, dTAG-13 and MG132 were purchased from Tocris Bioscience. Thalidomide was purchased from Sigma. All compounds were dissolved with DMSO (Merck Millipore).
+ Open protocol
+ Expand
7

BRD4, ERK, and MEK Inhibitor Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
BRD4 inhibitors were purchased from ApexBio (JQ1) and Cayman Chemical (OTX015) and used at a concentration of 1 μM. ERK inhibitor SCH772984 was purchased from Active Biochem and used at a concentration range of 250 nM-1 μM. MEK inhibitor trametinib was purchased from Selleckchem and used at a concentration range of 25–100 nM. All drugs were reconstituted in sterile, dry dimethyl sulfoxide, aliquotted, and store at −80 °C until further use.
+ Open protocol
+ Expand
8

SARS-CoV-2 Delta variant inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
All live virus experiments were performed in the BSL3 laboratory at the University of Nebraska Medical Center (Omaha, NE, USA). Calu-3 cells were plated in a 96 well transparent bottom black color plate (15000 cells/well) and cultured for 48 hours before infection. On the day of infection, the cells were treated with different concentrations of JQ1 (Cayman Chemical, Cat # 11187) or OTX015 (Cayman Chemical, Cat # 15947) (0.1 μM to 0.001 μM) two hours before infection. The cells were infected with SARS-CoV-2 (Delta variant of concern (VOC); pangolin linage: B.1.617.2, obtained from BEI Resources, NIAID, NIH; cat # 55672) with 0.5 MOI of viral titer or left uninfected (negative control). One hour post-infection, virus inoculum was removed from the cells, washed 3 times with 1X PBS, replenished with fresh media and treated with respective compounds. The reaction was terminated 24 hours post-infection. The culture supernatant was collected for measuring the viral replication kinetics, and the cells were washed and fixed with 4% PFA for immunofluorescence analysis.
+ Open protocol
+ Expand
9

Generation and Characterization of Mouse and Human MPNST Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary mouse MPNST (mMPNST) cells were generated via a mouse MPNST model as described previously (34 (link), 50 (link), 51 (link)). Human S462 MPNST cells were a kind gift from Karen Cichowski (Harvard Medical School). Human MPNST cells were authenticated with human-specific PCR primers on 9/18/18 to confirm the absence of mouse tumor cell contamination. All leukemia cell lines were a kind gift from Dr. Chengcheng Zhang (UT Southwestern, Dallas, TX). Routine mycoplasma testing of the cell lines was not performed. All cells were cultured in DMEM (10% FBS, 1% L-glutamine, 1% sodium pyruvate, 1% penicillin-streptomycin). Drugs used: JQ1 (Cayman Chemical and MedChem Express), OTX-015 (Cayman Chemical), CPI-203 (Cayman Chemical), CPI-0610 (Axon Medchem), ARV-771 and ARV-825 (MedChem Express).
+ Open protocol
+ Expand
10

SARS-CoV-2 Delta Variant Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
All live virus experiments were performed in the BSL3 laboratory at the University of Nebraska Medical Center (Omaha, NE, USA). Calu-3 cells were plated in a 96 well transparent bottom black color plate (15000 cells/well) and cultured for 48 h before infection. On the day of infection, the cells were treated with different concentrations of JQ1 (Cayman Chemical, Cat # 11187) or OTX015 (Cayman Chemical, Cat # 15947) (0.1 μM to 0.001 μM) two hours before infection. The cells were infected with SARS-CoV-2 (Delta variant of concern (VOC); pangolin linage: B.1.617.2, obtained from BEI Resources, NIAID, NIH; cat # 55672) with 0.5 MOI of viral titer or left uninfected (negative control). One hour post-infection, virus inoculum was removed from the cells, washed 3 times with 1X PBS, replenished with fresh media and treated with respective compounds. The reaction was terminated 24 h post-infection. The culture supernatant was collected for measuring the viral replication kinetics, and the cells were washed and fixed with 4% PFA for immunofluorescence analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!